Pandya gives an in-depth overview of his vitiligo treatment pearls from the 2023 Pigmentary Disorders Exchange Symposium.
Raj Chovatiya, MD, PhD, discusses how approved AD therapeutics currently address itch and whether any therapeutics will eventually have a remittive effect.
A new study on the gender pay gap in medicine examined earnings data from more than 80,000 doctors.
Fresh spins on established treatments and newly FDA-approved drugs and devices provide a framework for changing therapies and modalities for acne regimens.
Researchers from the University of Michigan and Almirall found that the profibrotic fibroblast response in HS can be modulated through inhibition of the Hippo pathway.
In an interview with Dermatology Times, the executive director of Pediatric Dermatology Research Alliance (PeDRA) discusses the group's growth since 2012 and what it can offer practicing dermatologists, researchers, students, and patients.
John Strasswimmer, MD, PhD comments on the impressive utility of both vismodegib and sonidegib in patients with advanced basal cell carcinoma and Jonathan S Zager, MD, FACS, FSSO provides his insight into the clinical utility of both of these treatments.
Ardon Health patients with autoimmune conditions have expressed common questions and concerns about COVID-19.
Experts discuss enhancing patient outcomes, comparing clobetasol cream concentrations, and more.
Melodie Young, MSN, ANP-c, shares pearls on why prioritizing skin checks during Psoriasis Action Month in August is critical.
In this month’s Finance & Practice Management column, we illustrate the importance of developing and maintaining a budget for physicians at all stages of their careers.
The first issue of Dermatology Times was published in 1979 to offer clinical insights into a growing health care specialty.
The HEROES program wants to make it easier for stylists to recognize scalp conditions and advise their clients to seek medical help.
Julapalli discusses her SPD 2024 lecture, "Rediscovering Joy in our Lives and the Workplace," excitement for the future of pediatric dermatology, and more.
The benefits include more accurate bacteria cell counts, more efficacious strains, and improved shelf life compared to non-heat-treated probiotics.
Peter Prieto, MD, MPH, shares details of the IOV-COM-202 trial.
Robert Posnick, MD, hosted a Case-Based Roundtable discussion to review 2 challenging cases of atopic dermatitis involving hyperpigmentation and alopecia areata.
Weekend treatment with cyclosporine may be beneficial for patients with moderate to severe psoriasis, according to a new study.
This special literature review yields a deeper understanding of issues like treating acne, nutraceuticals, and more.
These ratios will help you determine the level of financial stability of your practice and help you make better decisions for your future.
Patients prefer virtual appointments for common ailments, but question the quality of care.
In honor of National Healthy Skin Month, it is the perfect time to encourage patients to integrate gentle laser treatments into their yearly routine to maintain healthy, radiant skin.
Discover the evolving landscape of lupus treatment, from the importance of monitoring vitamin D levels to advancements in emerging therapies targeting type 1 interferon and plasmacytoid dendritic cells.